Lexicon Pharmaceuticals, Inc. (LXRX)

NCM – Real Time Price. Currency in USD

2.41

+0.10 (4.33%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

50M

31M

139K

Cost of goods sold

-895K

-1M

-639K

-427K

Gross Profit

49M

30M

565K

-288K

Operating expenses (excl. COGS)

-98M

-215M

-172M

-100M

Operating Income

-49M

-185M

-172M

-101M

Non-operating income, total

-1M

-16M

-5M

-1M

Pretax income

-50M

-200M

-177M

-102M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-50M

-200M

-177M

-102M

Lexicon Pharmaceuticals, Inc. (LXRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lexicon Pharmaceuticals, Inc. (LXRX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Lexicon Pharmaceuticals, Inc. (LXRX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Lexicon Pharmaceuticals, Inc. (LXRX)

Income Statement (Annual)

Income Statement (Annual)